AtriCure (ATRC) Depreciation and Depletion (2010 - 2026)

AtriCure (ATRC) has 17 years of Depreciation and Depletion data on file, last reported at $2.9 million in Q1 2026.

• Depreciation and Depletion for Q1 2026 came in at $2.9 million, down 2.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.0 million (up 3.5% YoY), and the FY2025 annual result was $12.1 million, up 7.81% from the prior year.
• Depreciation and Depletion fell to $2.9 million in Q1 2026 per ATRC's latest filing, from $3.0 million in the prior quarter.
• Over five years, Depreciation and Depletion peaked at $3.1 million in Q2 2025 and troughed at $1.9 million in Q1 2022.
• A 5-year average of $2.6 million and a median of $2.6 million in 2024 frame the typical range for Depreciation and Depletion.
• The sharpest annual moves came in 2022 and 2026: Depreciation and Depletion jumped 278.95% in 2022, then fell 2.86% in 2026.
• A 5-year view of Depreciation and Depletion shows it stood at $2.2 million in 2022, then climbed by 13.81% to $2.5 million in 2023, then advanced by 18.54% to $2.9 million in 2024, then grew by 1.9% to $3.0 million in 2025, then declined by 3.6% to $2.9 million in 2026.
• Business Quant data shows ATRC's Depreciation and Depletion at $2.9 million in Q1 2026, $3.0 million in Q4 2025, and $3.1 million in Q3 2025.